MedPath

Effects of soy beans isoflavone in the vagina and the uterum in the post menopausal womens

Phase 4
Conditions
Vaginal atrophyMenopauseTreatmentWomen
G08.686.157.500
C23.300.070
Registration Number
RBR-88vgp6
Lead Sponsor
FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
recruitment completed
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Women with age 45-68 years old
Vaginal atrophy simptons
Menopause >12 months
With out hot flushes
No contraindications for hormonal terapy

Exclusion Criteria

Hot flushes symptons
Breast neoplasy and endomtrium
With Hormonal teraphy

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The vaginal atrophy symptons with isoflavone gel will be less than placebo gel. The maturation index of vaginal citology will going to evaluated and by transvaginal ultrasonography the endometrium will going to evaluated
Secondary Outcome Measures
NameTimeMethod
There should be an increase in the number of the vaginal cells in use of isoflavone gel
© Copyright 2025. All Rights Reserved by MedPath